Try our beta test site
1 study found for:    19300261 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP

Study has passed its completion date and status has not been verified in more than two years.